These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 528055)

  • 1. Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations.
    Avery RJ; Niven J
    Infect Immun; 1979 Dec; 26(3):795-801. PubMed ID: 528055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newcastle disease virus antigens and strain variations.
    Schloer G; Spalatin J; Hanson RP
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):505-8. PubMed ID: 1124869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the use of monoclonal antibodies to hemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes.
    Meulemans G; Gonze M; Carlier MC; Petit P; Burny A; Le Long
    Arch Virol; 1987; 92(1-2):55-62. PubMed ID: 2432855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of monoclonal antibody-resistant mutants of Newcastle disease virus.
    Samson AC; Russell PH; Hallam SE
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():357-61. PubMed ID: 3838186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies identify a strain-specific epitope on the HN glycoprotein of Newcastle disease virus strain Australia-Victoria.
    Iorio RM; Lawton KA; Nicholson PM; Bratt MA
    Virus Res; 1984 Oct; 1(7):513-25. PubMed ID: 6085438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of pathotype-specific structural features and cleavage activation of Newcastle disease virus membrane glycoproteins using antipeptide antibodies.
    Hodder AN; Selleck PW; White JR; Gorman JJ
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1081-91. PubMed ID: 8509761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathotyping isolates of Newcastle disease virus using antipeptide antibodies to pathotype-specific regions of their fusion and hemagglutinin-neuraminidase proteins.
    Scanlon DB; Corino GL; Shiell BJ; Della-Porta AJ; Manvell RJ; Alexander DJ; Hodder AN; Gorman JJ
    Arch Virol; 1999; 144(1):55-72. PubMed ID: 10076509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of specific antibodies on biological functions of the envelope components of Newcastle disease virus.
    Seto JT; Becht H; Rott R
    Virology; 1974 Oct; 61(2):354-60. PubMed ID: 4213724
    [No Abstract]   [Full Text] [Related]  

  • 9. Newcastle disease virus: the effect of monoclonal antibody in the overlay on virus penetration and the immunoselection of variants.
    Russell PH
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():795-8. PubMed ID: 6546769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides.
    Kendal AP
    Virology; 1975 May; 65(1):87-99. PubMed ID: 49979
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons.
    Nishikawa K; Isomura S; Suzuki S; Watanabe E; Hamaguchi M; Yoshida T; Nagai Y
    Virology; 1983 Oct; 130(2):318-30. PubMed ID: 6196907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of field isolates of Newcastle disease virus using antipeptide antibodies.
    Hodder AN; Liu ZY; Selleck PW; Corino GL; Shiell BJ; Grix DC; Morrow CJ; Gorman JJ
    Avian Dis; 1994; 38(1):103-18. PubMed ID: 8002877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation of the hemagglutinin-neuraminidase and fusion glycoproteins of two biologically distinct strains of Newcastle disease virus.
    Smith GW; Schwalbe JC; Hightower LE
    Prog Clin Biol Res; 1980; 40():275-91. PubMed ID: 7454726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase content of strains of Newcastle disease virus which differ in virulence.
    McNulty MS; Gowans EJ; Houston MJ; Fraser G
    J Gen Virol; 1975 Jun; 27(3):399-402. PubMed ID: 1141865
    [No Abstract]   [Full Text] [Related]  

  • 15. The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein.
    Russell PH
    Arch Virol; 1986; 90(1-2):135-44. PubMed ID: 3729723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antibodies against Newcastle disease virus with syngeneic anti-idiotype antibodies in mice.
    Tanaka M; Sasaki N; Seto A
    Microbiol Immunol; 1986; 30(4):323-31. PubMed ID: 3487695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods of isolating six mutant classes from the Hickman strain of Newcastle disease virus.
    Estupinan J; Hanson RP
    Avian Dis; 1971; 15(4):798-804. PubMed ID: 5159550
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and purification of the envelope proteins of Newcastle disease virus.
    Scheid A; Choppin PW
    J Virol; 1973 Feb; 11(2):263-71. PubMed ID: 4734650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipeptide antibodies for analysis of pathotype-specific variations in cleavage activation of the membrane glycoprotein precursors of Newcastle disease virus isolates in cultured cells.
    Gorman JJ; Hodder AN; Selleck PW; Hansson E
    J Virol Methods; 1992 Apr; 37(1):55-70. PubMed ID: 1572931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus.
    Umino Y; Kohama T; Kohase M; Sugiura A; Klenk HD; Rott R
    Arch Virol; 1984; 81(1-2):53-65. PubMed ID: 6743025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.